Argentina vs Congo: HIV/AIDS deaths averted by antiretroviral therapy
Argentina
4,021 deaths
in 2024
Congo
4,099 deaths
in 2024
Argentina rank
46th
Congo rank
43rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Argentina
- Congo
How they compare
Congo currently reports 4,099 deaths against 4,021 deaths in Argentina, a difference of 78 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Congo ahead.
Argentina ranks 46th and Congo ranks 43rd of 157 countries.
Argentina has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Argentina | Congo | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 149.65 deaths | 0 deaths | 149.65 deaths | Argentina |
| 2000s | 2,595 deaths | 655.59 deaths | 1,939 deaths | Argentina |
| 2010s | 3,781 deaths | 2,300 deaths | 1,481 deaths | Argentina |
| 2020s | 4,018 deaths | 3,230 deaths | 788.45 deaths | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Argentina or Congo?
- Congo, at 4,099 deaths against 4,021 deaths in Argentina as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Argentina and Congo?
- 78 deaths, with Congo ahead.
- How many years of comparable data are there for Argentina and Congo?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Congo rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Argentina ranks 46th and Congo ranks 43rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.